PREVELENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ITS COMORBIDITIES – A REVIEW
Sivakshari Makkapati*, Akhila Yerubandi, Sreenu Thalla and Padmalatha Kantamneni
Chronic obstructive pulmonary disease [COPD] is a common, complex, heterogeneous condition in which it is responsible for growing morbidity and mortality. The study describes about the prevalence of COPD and its comorbidities in two different studies. Study 1, the prevalence of different comorbidities in COPD patients by gender and GOLD stage. This study was a non-interventional, cross-sectional investigation. Study 2, Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. This is an epidemiological cross-sectional study. The total number of patients involved in study 1 was 1,216. Males were 880 members and females were 336 members. The comorbidities mentioned were Cardiovascular, respiratory, Metabolic, Oncologic, Neuropsychiatric, Gastroenterology, Osteo – Articular and other diseases. The overall percentage of comorbidities found was 3,198 and the male percentage was 2,182 and the female percentage was 1,016. In study 2, the total population examined in this study was 7,731,628 who are NHS users. Out of which the 3,535,371 were about 45 years old and above. In that 462,894 were using respiratory agents. The number of male patients was 1,603,364 and the percentage is about 45% of ≥45 years of age and the number of patients exposed to ≥ 1 respiratory drug was 205,711 and the percentage was about 44%. The number of female patients was 1,932,007 and the percentage is about 55% of ≥45 years of age and the number of patients exposed to ≥1 respiratory drug was 257,183 and the percentage was about 56%.
Keywords: COPD, patients, prevalence, comorbidities, percentage.
[Full Text Article]